Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report, the global market for Human Albumin Injection should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Human Albumin Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Human Albumin Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Human albumin solutions are used in a range of medical and surgical problems.
This report studies and analyses global Human Albumin Injection status and future trends, helps the client to determine the Human Albumin Injection market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Human Albumin Injection, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Report Highlights
(1) Global Human Albumin Injection market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Human Albumin Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Human Albumin Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Human Albumin Injection key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Human Albumin Injection key producing regions, capacity, production, and year over year growth
(6) Human Albumin Injection industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Octapharma
CSL Behring
Biotest (UK) Ltd
Baxter
Kedrion Biopharma, Inc.
Grifols
GE HealthCare
Bio Products Laboratory
Green Cross
SK Plasma
Instituto Grifols
Takeda
Hualan Bio
Nanyue Biopharmaceuticals
Market segment by Type, covers
Blood Extraction
Recombine
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Key Findings from The Report:
Chapter 1: to describe Human Albumin Injection product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Human Albumin Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Human Albumin Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Human Albumin Injection, percent & CAGR, 2018-2029
Chapter 5: Human Albumin Injection industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Human Albumin Injection Definition
1.2 Global Human Albumin Injection Market Size and Forecast
1.2.1 By Consumption Value, Global Human Albumin Injection Market Size,2018-2029
1.2.2 By Sales Quantity, Global Human Albumin Injection Market Size,2018-2029
1.2.3 Global Human Albumin Injection Average Selling Price (ASP),2018-2029
1.3 China Human Albumin Injection Market Size and Forecast
1.3.1 By Consumption Value, China Human Albumin Injection Market Size,2018-2029
1.3.2 By Sales Quantity, China Human Albumin Injection Market Size,2018-2029
1.3.3 China Human Albumin Injection Average Selling Price (ASP), 2018-2029
1.4 Share of China Human Albumin Injection Market with Respect to the Global Market
1.4.1 By Consumption Value, China Human Albumin Injection Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Human Albumin Injection Market Share in Global, 2018-2029
1.4.3 Human Albumin Injection Market Size: China VS Global, 2018-2029
1.5 Human Albumin Injection Market Dynamics
1.5.1 Human Albumin Injection Market Drivers
1.5.2 Human Albumin Injection Market Restraints
1.5.3 Human Albumin Injection Industry Trends
1.5.4 Human Albumin Injection Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Human Albumin Injection, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Human Albumin Injection, Global Market Share by Company, 2018-2023
2.3 Human Albumin Injection Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Human Albumin Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Human Albumin Injection Concentration Ratio
2.6 Global Human Albumin Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Human Albumin Injection Manufacturers Product Type
2.8 Head Office and Human Albumin Injection Production Site of Key Manufacturer
2.9 Human Albumin Injection Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Human Albumin Injection, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Human Albumin Injection, China Market Share by Company, 2018-2023
3.3 China Human Albumin Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Human Albumin Injection Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Human Albumin Injection Capacity by Region
4.3 Global Human Albumin Injection Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Human Albumin Injection Production by Region, 2018-2029
4.5 Global Human Albumin Injection Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Human Albumin Injection Industry Chain
5.2 Human Albumin Injection Upstream Analysis
5.2.1 Human Albumin Injection Core Raw Materials
5.2.2 Main Manufacturers of Human Albumin Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Human Albumin Injection Production Mode
5.6 Human Albumin Injection Procurement Model
5.7 Human Albumin Injection Industry Sales Model and Sales Channels
5.7.1 Human Albumin Injection Sales Model
5.7.2 Human Albumin Injection Typical Distributors
6 Sights by Type
6.1 Human Albumin Injection Classification
6.1.1 Blood Extraction
6.1.2 Recombine
6.2 By Type, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Human Albumin Injection Consumption Value, 2018-2029
6.4 By Type, Global Human Albumin Injection Sales Quantity, 2018-2029
6.5 By Type, Global Human Albumin Injection Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Human Albumin Injection Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Human Albumin Injection Consumption Value, 2018-2029
7.4 By Application, Global Human Albumin Injection Sales Quantity, 2018-2029
7.5 By Application, Global Human Albumin Injection Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Human Albumin Injection Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Human Albumin Injection Consumption Value, 2018-2029
8.3 By Region, Global Human Albumin Injection Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Human Albumin Injection & Forecasts, 2018-2029
8.4.2 By Country, North America Human Albumin Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Human Albumin Injection Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Human Albumin Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Human Albumin Injection Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Human Albumin Injection Market Size Market Share
8.7 South America
8.7.1 South America Human Albumin Injection Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Human Albumin Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Human Albumin Injection Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Human Albumin Injection Consumption Value, 2018-2029
9.3 By Country, Global Human Albumin Injection Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Human Albumin Injection Market Size, 2018-2029
9.4.2 By Type, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Human Albumin Injection Market Size, 2018-2029
9.5.2 By Type, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Human Albumin Injection Market Size, 2018-2029
9.6.2 By Type, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Human Albumin Injection Market Size, 2018-2029
9.7.2 By Type, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Human Albumin Injection Market Size, 2018-2029
9.8.2 By Type, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Human Albumin Injection Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Human Albumin Injection Market Size, 2018-2029
9.10.2 By Type, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Human Albumin Injection Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Octapharma
10.1.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
10.1.2 Octapharma Human Albumin Injection Models, Specifications, and Application
10.1.3 Octapharma Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Octapharma Company Profile and Main Business
10.1.5 Octapharma Recent Developments
10.2 CSL Behring
10.2.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position
10.2.2 CSL Behring Human Albumin Injection Models, Specifications, and Application
10.2.3 CSL Behring Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 CSL Behring Company Profile and Main Business
10.2.5 CSL Behring Recent Developments
10.3 Biotest (UK) Ltd
10.3.1 Biotest (UK) Ltd Company Information, Head Office, Market Area, and Industry Position
10.3.2 Biotest (UK) Ltd Human Albumin Injection Models, Specifications, and Application
10.3.3 Biotest (UK) Ltd Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Biotest (UK) Ltd Company Profile and Main Business
10.3.5 Biotest (UK) Ltd Recent Developments
10.4 Baxter
10.4.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.4.2 Baxter Human Albumin Injection Models, Specifications, and Application
10.4.3 Baxter Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Baxter Company Profile and Main Business
10.4.5 Baxter Recent Developments
10.5 Kedrion Biopharma, Inc.
10.5.1 Kedrion Biopharma, Inc. Company Information, Head Office, Market Area, and Industry Position
10.5.2 Kedrion Biopharma, Inc. Human Albumin Injection Models, Specifications, and Application
10.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Kedrion Biopharma, Inc. Company Profile and Main Business
10.5.5 Kedrion Biopharma, Inc. Recent Developments
10.6 Grifols
10.6.1 Grifols Company Information, Head Office, Market Area, and Industry Position
10.6.2 Grifols Human Albumin Injection Models, Specifications, and Application
10.6.3 Grifols Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Grifols Company Profile and Main Business
10.6.5 Grifols Recent Developments
10.7 GE HealthCare
10.7.1 GE HealthCare Company Information, Head Office, Market Area, and Industry Position
10.7.2 GE HealthCare Human Albumin Injection Models, Specifications, and Application
10.7.3 GE HealthCare Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 GE HealthCare Company Profile and Main Business
10.7.5 GE HealthCare Recent Developments
10.8 Bio Products Laboratory
10.8.1 Bio Products Laboratory Company Information, Head Office, Market Area, and Industry Position
10.8.2 Bio Products Laboratory Human Albumin Injection Models, Specifications, and Application
10.8.3 Bio Products Laboratory Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bio Products Laboratory Company Profile and Main Business
10.8.5 Bio Products Laboratory Recent Developments
10.9 Green Cross
10.9.1 Green Cross Company Information, Head Office, Market Area, and Industry Position
10.9.2 Green Cross Human Albumin Injection Models, Specifications, and Application
10.9.3 Green Cross Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Green Cross Company Profile and Main Business
10.9.5 Green Cross Recent Developments
10.10 SK Plasma
10.10.1 SK Plasma Company Information, Head Office, Market Area, and Industry Position
10.10.2 SK Plasma Human Albumin Injection Models, Specifications, and Application
10.10.3 SK Plasma Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 SK Plasma Company Profile and Main Business
10.10.5 SK Plasma Recent Developments
10.11 Instituto Grifols
10.11.1 Instituto Grifols Company Information, Head Office, Market Area, and Industry Position
10.11.2 Instituto Grifols Human Albumin Injection Models, Specifications, and Application
10.11.3 Instituto Grifols Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Instituto Grifols Company Profile and Main Business
10.11.5 Instituto Grifols Recent Developments
10.12 Takeda
10.12.1 Takeda Company Information, Head Office, Market Area, and Industry Position
10.12.2 Takeda Human Albumin Injection Models, Specifications, and Application
10.12.3 Takeda Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Takeda Company Profile and Main Business
10.12.5 Takeda Recent Developments
10.13 Hualan Bio
10.13.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
10.13.2 Hualan Bio Human Albumin Injection Models, Specifications, and Application
10.13.3 Hualan Bio Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Hualan Bio Company Profile and Main Business
10.13.5 Hualan Bio Recent Developments
10.14 Nanyue Biopharmaceuticals
10.14.1 Nanyue Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Models, Specifications, and Application
10.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Nanyue Biopharmaceuticals Company Profile and Main Business
10.14.5 Nanyue Biopharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Human Albumin Injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Albumin Injection Market Restraints
Table 3. Human Albumin Injection Market Trends
Table 4. Human Albumin Injection Industry Policy
Table 5. Global Human Albumin Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Human Albumin Injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Human Albumin Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Human Albumin Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Human Albumin Injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Human Albumin Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Human Albumin Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Human Albumin Injection Manufacturers Product Type
Table 13. Head Office and Human Albumin Injection Production Site of Key Manufacturer
Table 14. Human Albumin Injection Capacity of Major Manufacturers and Future Plan
Table 15. China Human Albumin Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Human Albumin Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Human Albumin Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Human Albumin Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Human Albumin Injection Production by Region, 2018-2023, (K Units)
Table 20. Global Human Albumin Injection Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Human Albumin Injection Upstream (Raw Materials)
Table 22. Global Human Albumin Injection Typical Customers
Table 23. Human Albumin Injection Typical Distributors
Table 24. By Type, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Human Albumin Injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Table 34. Octapharma Company Information, Head Office, Market Area, and Industry Position
Table 35. Octapharma Human Albumin Injection Models, Specifications, and Application
Table 36. Octapharma Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Octapharma Company Profile and Main Business
Table 38. Octapharma Recent Developments
Table 39. CSL Behring Company Information, Head Office, Market Area, and Industry Position
Table 40. CSL Behring Human Albumin Injection Models, Specifications, and Application
Table 41. CSL Behring Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. CSL Behring Company Profile and Main Business
Table 43. CSL Behring Recent Developments
Table 44. Biotest (UK) Ltd Company Information, Head Office, Market Area, and Industry Position
Table 45. Biotest (UK) Ltd Human Albumin Injection Models, Specifications, and Application
Table 46. Biotest (UK) Ltd Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Biotest (UK) Ltd Company Profile and Main Business
Table 48. Biotest (UK) Ltd Recent Developments
Table 49. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 50. Baxter Human Albumin Injection Models, Specifications, and Application
Table 51. Baxter Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Baxter Company Profile and Main Business
Table 53. Baxter Recent Developments
Table 54. Kedrion Biopharma, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 55. Kedrion Biopharma, Inc. Human Albumin Injection Models, Specifications, and Application
Table 56. Kedrion Biopharma, Inc. Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Kedrion Biopharma, Inc. Company Profile and Main Business
Table 58. Kedrion Biopharma, Inc. Recent Developments
Table 59. Grifols Company Information, Head Office, Market Area, and Industry Position
Table 60. Grifols Human Albumin Injection Models, Specifications, and Application
Table 61. Grifols Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Grifols Company Profile and Main Business
Table 63. Grifols Recent Developments
Table 64. GE HealthCare Company Information, Head Office, Market Area, and Industry Position
Table 65. GE HealthCare Human Albumin Injection Models, Specifications, and Application
Table 66. GE HealthCare Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. GE HealthCare Company Profile and Main Business
Table 68. GE HealthCare Recent Developments
Table 69. Bio Products Laboratory Company Information, Head Office, Market Area, and Industry Position
Table 70. Bio Products Laboratory Human Albumin Injection Models, Specifications, and Application
Table 71. Bio Products Laboratory Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Bio Products Laboratory Company Profile and Main Business
Table 73. Bio Products Laboratory Recent Developments
Table 74. Green Cross Company Information, Head Office, Market Area, and Industry Position
Table 75. Green Cross Human Albumin Injection Models, Specifications, and Application
Table 76. Green Cross Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Green Cross Company Profile and Main Business
Table 78. Green Cross Recent Developments
Table 79. SK Plasma Company Information, Head Office, Market Area, and Industry Position
Table 80. SK Plasma Human Albumin Injection Models, Specifications, and Application
Table 81. SK Plasma Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. SK Plasma Company Profile and Main Business
Table 83. SK Plasma Recent Developments
Table 84. Instituto Grifols Company Information, Head Office, Market Area, and Industry Position
Table 85. Instituto Grifols Human Albumin Injection Models, Specifications, and Application
Table 86. Instituto Grifols Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Instituto Grifols Company Profile and Main Business
Table 88. Instituto Grifols Recent Developments
Table 89. Takeda Company Information, Head Office, Market Area, and Industry Position
Table 90. Takeda Human Albumin Injection Models, Specifications, and Application
Table 91. Takeda Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Takeda Company Profile and Main Business
Table 93. Takeda Recent Developments
Table 94. Hualan Bio Company Information, Head Office, Market Area, and Industry Position
Table 95. Hualan Bio Human Albumin Injection Models, Specifications, and Application
Table 96. Hualan Bio Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Hualan Bio Company Profile and Main Business
Table 98. Hualan Bio Recent Developments
Table 99. Nanyue Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 100. Nanyue Biopharmaceuticals Human Albumin Injection Models, Specifications, and Application
Table 101. Nanyue Biopharmaceuticals Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Nanyue Biopharmaceuticals Company Profile and Main Business
Table 103. Nanyue Biopharmaceuticals Recent Developments
List of Figures
Figure 1. Human Albumin Injection Picture
Figure 2. Global Human Albumin Injection Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Human Albumin Injection Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Human Albumin Injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Human Albumin Injection Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Human Albumin Injection Sales Quantity (K Units) & (2018-2029)
Figure 7. China Human Albumin Injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Human Albumin Injection Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Human Albumin Injection Market Share of Global, 2018-2029
Figure 10. Global Human Albumin Injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Human Albumin Injection Key Participants, Market Share, 2022
Figure 12. Global Human Albumin Injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Human Albumin Injection Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Human Albumin Injection Production Market Share & Forecast by Region, 2018-2029
Figure 15. Human Albumin Injection Industry Chain
Figure 16. Human Albumin Injection Procurement Model
Figure 17. Human Albumin Injection Sales Model
Figure 18. Human Albumin Injection Sales Channels, Direct Sales, and Distribution
Figure 19. Blood Extraction
Figure 20. Recombine
Figure 21. By Type, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Human Albumin Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Clinic
Figure 28. By Application, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Human Albumin Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Figure 35. North America Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Human Albumin Injection Consumption Value Market Share, 2022
Figure 37. Europe Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Human Albumin Injection Consumption Value Market Share, 2022
Figure 39. Asia Pacific Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Human Albumin Injection Consumption Value Market Share, 2022
Figure 41. South America Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Human Albumin Injection Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 50. China Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 62. India Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches
Research Methodology:
Human Albumin Injection Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|